Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2013­2014

Takashita, Emi; Meijer, Adam; Lackenby, Angie; Gubareva, Larisa; Andrade, Helena Rebelo de; Besselar, Terry; Fry, Alicia; Gregory, Vicky; Leang, Sook-Kwan; Huang, Weijuan; Lo, Janice; Pereyaslov, Dmitriy; Siqueira, Marilda Agudo Mendonça Teixeira de; Wang, Dayan; Mak, Gannon C.; Zhang, Wenqing; Daniels, Rod S.; Hurt, Aeron C.; Tashiro, Masato.
Artículo en Inglés | ARCA | ID: arc-13427

Documentos relacionados

  1. Discovery of a potent inhibitor targeting the cap-binding domain of the PB2 subunit of influenza RNA-dependent RNA polymerase.
  2. Executive summary - Diagnosis, treatment and prophylaxis of influenza virus infection - Consensus statement of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), the Spanish Society of Pediatric Infectious Diseases (SEIP), the Spanish Association of Vaccinology (AEV), the Spanish Society of Family and Community Medicine (SEMFYC) and the Spanish Society of Preventive Medicine, Public Health and Health Management (SEMPSPGS).
  3. Comparisons in the Health and Economic Assessments of Using Quadrivalent Versus Trivalent Influenza Vaccines: A Systematic Literature Review.
  4. Addressing delayed case reporting in infectious disease forecast modeling.
  5. Living With the Flu: Public Health and Civic Life During the Spanish Influenza Pandemic of 1918.
  6. Baloxavir and Treatment-Emergent Resistance: Public Health Insights and Next Steps.
  7. Reply to Bracher: Scoring probabilistic forecasts to maximize public health interpretability.
  8. Regulatory scientists' work has important ramifications for public health and should be open to public scrutiny.
  9. Body and Soul: Health Collaborations With Faith-Based Organizations.
  10. Re: Letter to the Editor of Public Health in response to 'Vaccination against pertussis and influenza in pregnancy: a qualitative study of barriers and facilitators.'